Although, in this study, we confirm the increased expression of both CD44s and CD166 from normal adjacent colorectal tissue to cancer, our results support the association of loss (rather than increase) of membranous CD44s and CD166 with aggressive tumour-related features such as more advanced pT stage, pN stage, vascular invasion, and an infiltrating tumour growth pattern. The gene discussed is ALCAM; the disease is cancer.